---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-122379"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T19:06:12.460303+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TransCode shareholders approve 10M share offering and reverse stock split at special meeting

## Summary
- Ratified issuance of 10M shares of common stock and warrants to ThinkEquity LLC via best-efforts public offering.
- Approved reverse stock split at ratio between 1:10 and 1:40, with timing at Board's discretion.
- Ratification Proposal: 3,659,491 for, 1,094,753 against, 70,611 abstain (4,655,205 broker non-votes).
- Reverse Stock Split Proposal: 7,271,421 for, 2,012,687 against, 195,952 abstain; no broker non-votes.
- Adjournment Proposal approved but not needed; total shares present at meeting: 9,480,060 of 17,265,658 entitled.

## SEC filing metadata
- accession: 0001104659-24-122379
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465924122379/0001104659-24-122379-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465924122379/tm2429410d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-122379
- JSON: https://secwatch.observer/filing/0001104659-24-122379.json
- Plain text: https://secwatch.observer/filing/0001104659-24-122379.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.